hip resurfacing system Tagged Articles

DePuy’s tests on metal artificial hip system failed to show potential dangers of device

Posted: March 26, 2013 Pharmaceutical

Orthopedic doctors were optimistic when metal-on-metal hip replacement systems were first introduced around the world. They offered a seemingly more durable alternative to traditional ceramic or plastic artificial hips. The devices were especially attractive to younger recipients, who wanted to go

British MPs call for criminal inquiry into toxic DePuy hip implants

Posted: March 3, 2013 Pharmaceutical

British MPs have called for an investigation into DePuy Orthopaedics after testimony from a U.S. court case revealed that the medical device company continued to sell defective artificial hip implants despite knowing for at least three years they were toxic

DePuy recalls device used in knee revision surgery

Posted: February 25, 2013 Recalls

DePuy Orthopaedics is recalling the LPS Diaphyseal Sleeve used in knee revision surgery because of a defect that can result in loss of function or loss of limb, infection, compromised soft tissue or death. The recall is classified as a

Johnson and Johnson recalls another metal-on-metal hip implant

Posted: February 18, 2013 Pharmaceutical

Johnson & Johnson is recalling thousands more metal-on-metal hip replacement systems because of early failures. The recall comes 2 ½ years after the company recalled the DePuy Orthopaedics ASR metal-on-metal hip replacement system and hip resurfacing system for similar problems,

Johnson and Johnson internal analysis shows recalled hip implant could have 40 percent failure risk

Posted: January 31, 2013 Pharmaceutical

Not long after health care giant Johnson & Johnson and its subsidiary DePuy Orthopaedics issued a worldwide recall of the ASR hip replacement system and ASR hip resurfacing system due to a higher rate of premature failures than competitive devices,

Johnson and Johnson to focus on medical devices, new drugs in 2013

Posted: January 23, 2013 Pharmaceutical

Medical devices, new prescription drugs in development, and righting manufacturing problems will be the focus of health care giant Johnson & Johnson’s efforts in 2013, the company announced. Johnson & Johnson is rolling out this week its fourth-quarter results along

FDA proposes requiring makers of metal hips to submit premarket approval applications

Posted: January 20, 2013 Pharmaceutical

The Food and Drug Administration (FDA) is proposing requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval applications in order to assess risks associated with the devices. The proposed order was announced Thursday along with updated safety information

FDA warns doctors, patients about risks associated with metal-on-metal hip implants

Posted: January 19, 2013 Pharmaceutical

The Food and Drug Administration (FDA) released updated safety information to patients and health care providers about risks associated with metal-on-metal hip replacement systems and metal-on-metal hip resurfacing systems based on the agency’s current assessment of the implant and results

International safety alert issued on metal hip device

Posted: November 28, 2012 Pharmaceutical

Medsafe, New Zealand Medicines and Medical Devices Safety Authority, has issued an international safety alert on the Durom Acetabular Cup, an artificial hip device that was discontinued by its manufacturer in June 2011. The device has been failing at a

Johnson and Johnson completes merger with troubled artificial hip maker

Posted: June 15, 2012 Pharmaceutical

Johnson & Johnson has completed its acquisition of Synthes, Inc. and will integrate Synthes with its subsidiary DePuy Orthopaedics to establish the DePuy Synthes Companies of Johnson & Johnson. The deal was sealed with $19.7 billion in cash and stock.